Full Text View
Tabular View
No Study Results Posted
Related Studies
Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
This study is currently recruiting participants.
Study NCT00504244.   Last updated on July 18, 2007.
Information provided by Erasmus Medical Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Lupus Erythematosus, Systemic
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Interventions listed in this trial
switch to Myfortic
continuation of azathioprine
Additional drug interventions recognized in this trial
Azathioprine
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Erasmus Medical Center
Novartis


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services